1. Home
  2. PODD vs GFL Comparison

PODD vs GFL Comparison

Compare PODD & GFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • GFL
  • Stock Information
  • Founded
  • PODD 2000
  • GFL 2007
  • Country
  • PODD United States
  • GFL Canada
  • Employees
  • PODD N/A
  • GFL N/A
  • Industry
  • PODD Medical/Dental Instruments
  • GFL
  • Sector
  • PODD Health Care
  • GFL
  • Exchange
  • PODD Nasdaq
  • GFL Nasdaq
  • Market Cap
  • PODD 16.5B
  • GFL 18.1B
  • IPO Year
  • PODD 2007
  • GFL 2020
  • Fundamental
  • Price
  • PODD $282.80
  • GFL $46.33
  • Analyst Decision
  • PODD Buy
  • GFL Strong Buy
  • Analyst Count
  • PODD 16
  • GFL 9
  • Target Price
  • PODD $291.81
  • GFL $49.00
  • AVG Volume (30 Days)
  • PODD 598.2K
  • GFL 1.7M
  • Earning Date
  • PODD 02-20-2025
  • GFL 02-24-2025
  • Dividend Yield
  • PODD N/A
  • GFL 0.12%
  • EPS Growth
  • PODD 96.40
  • GFL N/A
  • EPS
  • PODD 5.78
  • GFL N/A
  • Revenue
  • PODD $2,071,600,000.00
  • GFL $5,743,291,755.00
  • Revenue This Year
  • PODD $23.56
  • GFL $5.50
  • Revenue Next Year
  • PODD $18.07
  • GFL $6.52
  • P/E Ratio
  • PODD $48.93
  • GFL N/A
  • Revenue Growth
  • PODD 22.07
  • GFL 4.09
  • 52 Week Low
  • PODD $160.19
  • GFL $30.57
  • 52 Week High
  • PODD $289.46
  • GFL $48.87
  • Technical
  • Relative Strength Index (RSI)
  • PODD 54.94
  • GFL 60.71
  • Support Level
  • PODD $270.00
  • GFL $45.76
  • Resistance Level
  • PODD $288.95
  • GFL $46.66
  • Average True Range (ATR)
  • PODD 6.83
  • GFL 0.90
  • MACD
  • PODD -0.31
  • GFL 0.15
  • Stochastic Oscillator
  • PODD 65.78
  • GFL 78.93

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About GFL GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. GFL's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.

Share on Social Networks: